AIM2 DISCOVERY CENTER Trademark
AIM2 DISCOVERY CENTER is a USPTO trademark filed by Pfizer Inc.. Status: Pending.
Trademark Facts
| Mark | AIM2 DISCOVERY CENTER |
|---|---|
| Serial Number | 99782654 |
| Status | Pending |
| Filing Date | 2026-04-23 |
| Mark Type | Stylized |
| Nice Classes | 042 (Software & IT) |
| Owner | Pfizer Inc. |
| Attorney of Record | Andrea Christensen |
| Prosecution Events | 2 |
| Latest Event | MAFR on 2026-04-23 |
Goods & Services
Class 042: Pharmaceutical research and development; Medical and scientific research in the field of cardiometabolic disease using artificial intelligence
Mark Details
| Mark Drawing Description | The mark consists of the text “AIM² Discovery Center”, the word “AIM” is followed by a superscript “2". |
|---|
Recent Prosecution Activity
| Date | Code | Type | Description |
|---|---|---|---|
| 2026-04-23 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| 2026-04-23 | NWAP | I | NEW APPLICATION ENTERED |
Other Trademarks from Pfizer Inc.
Pfizer Inc. owns 5 USPTO trademarks (5 live).
Nice Class Context
- Class 042 (Software & IT) — 352450 live marks in this class